Infants born at 22 to 24 weeks’ gestation at one academic medical center in 2001 to 2003 were found to be at an increased risk than infants who were born between 1993 and 1995 and benefited from less of life-sustaining interventions and still enjoyed a better survival rate.
The finding was reported in [...]
May 28, 2010 | Posted in
Steroids Blog |
Read More »
Dostinex (Cabergoline), which is used in treating hormone imbalances involving excess prolactin, has been helping many patients suffering from bodily disorders. The drug that is also used to treat hyperprolactinemic (idiopathic and pituitary adenomas) disorders along with minimizing breast milk production has been considered to be a drug with fewer side-effects.
In medical terms, dostinex is [...]
June 27, 2009 | Posted in
Steroid Profiles |
Read More »